USDNew York Stock ExchangeDelayed PriceMarket Closed Earnings High Target Price 45.00 Mean Target Price 31.43 Low Target Price 25.00 Standard Deviation: 4.20 Number of Estimates 21 Date of Most Recent Estimate 12/18/24 # Estimates: 2125303540452050 Mean31.43 High45.00 Low25.00 Price Estimate# Estimate...
PFE Stock 12 Month Forecast $31.56 ▲(24.99% Upside) Based on19Wall Street analysts offering 12 month price targets forPfizerin the last3 months. The average price target is$31.56with a high forecast of$45.00and a low forecast of$25.00. The average price target represents a24.99%change from...
Pfizer price target lowered to $29 from $31 at UBS Jan. 8, 2025 at 6:45 a.m. ETon TipRanks.com Prediction: These Could Be the Best-Performing Value Stocks Through 2030 Jan. 8, 2025 at 5:48 a.m. ETon Motley Fool Pfizer Inc. ...
PFE Stock 12 Month Forecast All Analysts Top Analysts Average Price Target $31.56 ▲(24.99% Upside) Past 12 Months12 Month ForecastMar2024Dec2024 High $45.00 Average $31.56 Low $25.00 Detailed Analyst Forecast > Technical Analysis 1 Day 3 Days 1 Week 1 Month Overall Consensus ...
Pfizer unexpectedly terminated the hemophilia agreement, causing Sangamo (SGMO.US) stock price to plummet over 69% in after-hours trading. Sangamo stated in a press release on Monday Eastern Time that the company is considering "all options" to continue the development of this new drug, including...
Sell Buy Mean consensus OUTPERFORM Number of Analysts 25 Last Close Price 26.42USD Average target price 31.86USD Spread / Average Target +20.60% Consensus Profit revisions Estimate revisions My Watchlist My lists Currency / Forex Commodities
Moderna’s Stock-Price Target Slashed. It’s About Vaccines. Oct. 28, 2024 9:28 a.m. ET What the Election Will Mean for CVS, Pfizer, and Other Healthcare Stocks Oct. 26, 2024 12:29 p.m. ET Who Should Get Covid and Flu Vaccines This Year—and the Best Time to Get Them Oct....
PFE Stock USD 26.42 0.20 0.75% At the present time, the relative strength index (RSI) of Pfizer's share price is approaching 41 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are...
USDNew York Stock ExchangeDelayed Price Earnings High Target Price 45.00 Mean Target Price 31.33 Low Target Price 25.00 Standard Deviation: 4.23 Number of Estimates 21 Date of Most Recent Estimate 01/16/25 Price Estimate# EstimatesHighMeanLow# Estimates3 Week2 Week1 WeekCurrent01020304050212223242526 ...
This new authorization represented approximately 10.1% of shares outstanding at the stock price at the time of the announcement.Sale of select assets of BioReference Health expected to close toward the end of the third quarter. OPKO entered into an agreement in March 2024 to sell BioReference ...